IP Library Granted Patent US 8,246,549
Granted Patent B2
US 8,246,549 · App. 10/588,221 · Granted Aug 21, 2012

Method for predicting stroke and pain in a human patient

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,246,549
App. No.
10/588,221
Granted
Aug 21, 2012
Kind
B2
Abstract

A method for predicting the onset of any (NO)-related negative influence of hemolysis, such as pain or the likely occurrence of a stroke, in a human patient by detecting abnormal levels of hemolysis, through the measurement of one or more breath gas concentrations.

Claims (7)

1. A method for predicting the onset of at least one nitric oxide-related negative influence in a human patient, said method comprising:

providing an electronic device;

measuring a concentration level of at least one breath gas exhaled by the patient over a period of time;

comparing the measured concentration levels with a predetermined concentration profile indicative of an onset of at least one selected nitric oxide-related negative influence; and

wherein said at least one selected nitric oxide-related negative influence is associated with an intravascular hemoglobin-dependent decrease in nitric oxide bioavailability, wherein said step of comparing is carried out by the electronic device.

2. The method of claim 1 wherein said nitric oxide-related negative influence includes nitric oxide-related negative influences of hemolysis in a human patient and nitric oxide-related negative influences of chronic hereditary hemolytic disease in a human patient.

3. The method of claim 2 wherein said one or more nitric oxide-related negative influences of chronic hereditary hemolytic disease include one or more pathologies from a set of pathologies including pulmonary hypertension, cutaneous ulceration, renal failure, thrombotic thrombocytopenic purpura, and malaria.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2014
From: EVEREST BIOMEDICAL INSTRUMENTS COMPANY
To: STRYKER CORPORATION
Reel/Frame 032213/0454 →